High risk HPV types in southern Iranian patients with cervical cancer

Farjadian, Shirin; Asadi, E; Doroudchi, Mehrnoosh; Dehaghani, Alamtaj Samsami; Tabei, S. Z.; Kumar, Perikala V.; Ghaderi, Abbas

doi:10.1007/bf03033756

Cited by 31 publications

(23 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence in others studies were variable; and this variability may be contributed to ethnic and geographic factors. The prevalence rate of HPV 16 among Iranian patients [21] with cervical carcinoma was reported to be 6.7%. In the present study, the prevalence of HPV 16 among patients with cervical cancer was higher [22] than Croatia (50%), Australia (53%), Thailand (41%), Italy (32.6%), China (48.8%), and the Philippines (43.9%); and was lower than in Colombia (69.9%), Spain (66.4%), and Morocco (72.4%) [20].…”

Section: Discussionmentioning

confidence: 99%

The prevalence and pattern of HPV-16 immunostaining in uterine cervical carcinomas in Ethiopian women: a pilot study

Rashed¹,

Bekele²

2011

Pan Afr Med Jrnl

View full text Add to dashboard Cite

IntroductionCancer of the cervix uteri is the second most common cancer among women worldwide. The association of human papillomavirus (HPV) infection with cervical carcinogenesis is well documented. This is a pilot study aiming to studying the prevalence and the pattern of Human Papilloma Virus Type 16 (HPV16) by immunostaining in the tissues of cervical carcinomas of Ethiopian women.Methods20 specimens of uterine cervical carcinomas were studied histopathologically and immunohistochemically for HPV16. ResultsHistologically the specimens were classified as: Ten cases were Non Keratinized Squamous cell carcinoma (NKSCC), six cases were Keratinized Squamous Cell Carcinoma (KSCC) and four cases were Adenocarcinoma (ADC). Immunohistochemistry study showed positivity in eleven cases (55%); seven cases (35%) were non-keratinized squamous cell carcinoma; three cases (15%) were keratinized squamous cell carcinoma and one case (5%) belonged to the adenocarcinomas.ConclusionThis study reveals a significant detection of HPV in Ethiopian women by the use of advanced techniques such as Immunohistochemistry (IHC). The data of this study suggested that the marked expression of the HPV 16 was in the less differentiated uterine cervix carcinomas.

show abstract

Section: Discussionmentioning

confidence: 99%

The prevalence and pattern of HPV-16 immunostaining in uterine cervical carcinomas in Ethiopian women: a pilot study

Rashed¹,

Bekele²

2011

Pan Afr Med Jrnl

View full text Add to dashboard Cite

show abstract

“…In Morocco, 70.5% of invasive carcinoma cases were HPV positive, 34.88% cases had HPV16, and 15.5% cases had HPV18 [52]. In Iran, controversial data were reported; 73.9% of HPV positive cacx contained HPV16 [53], while in another study HPV16 was identified in 26.7% and none of the samples were positive for HPV18 [54]. …”

Section: Discussionmentioning

confidence: 99%

Prevalence of cervical neoplastic lesions and Human Papilloma Virus infection in Egypt: National Cervical Cancer Screening Project

All

Refaat

Dandash

2007

Infect Agents Cancer

View full text Add to dashboard Cite

Background: Data from Egyptian studies provide widely varying estimates on the prevalence of premalignant and malignant cervical abnormalities and human papilloma virus (HPVs) infection. To define the prevalence and risk factors of pre-invasive and invasive cervical cancer (cacx), a community based full-scale cross sectional, household survey including 5453 women aged between 35 and 60 years was conducted.

show abstract

“…Network structure and concurrency of partnerships play a major role in HIV transmission (Farjadian et al 2003; Kretzschmar et al 1996; Morris 1997; Watts et al 1992): a monogamous member of a stable sexual partnership can be at high risk of infection because of connection through a primary partner, or a partner of a primary partner, to a high-risk sexual network. Conversely, a person with frequent partnership change remains at low risk if his/her network is closed with low risk of HIV penetration.…”

Section: Introductionmentioning

confidence: 99%

HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa

et al. 2010

View full text Add to dashboard Cite

Background HIV prevalence is low in the Middle East and North Africa (MENA) region, though the risk or potential for further spread in the future is not well understood. Behavioral surveys are limited in this region and when available have serious limitations in assessing the risk of HIV acquisition. We demonstrate the potential use of herpes simplex virus-2 (HSV-2) seroprevalence as a marker for HIV risk within MENA. Methods We designed a mathematical model to assess whether HSV-2 prevalence can be predictive of future HIV spread. We also conducted a systematic literature review of HSV-2 seroprevalence studies within MENA. Results We found that HSV-2 prevalence data are rather limited in this region. Prevalence is typically low among the general population but high in established core groups prone to sexually transmitted infections such as men who have sex with men and female sex workers. Our model predicts that if HSV-2 prevalence is low and stable, then the risk of future HIV epidemics is low. However, expanding or high HSV-2 prevalence (greater than about 20%), implies a risk for a considerable HIV epidemic. Based on available HSV-2 prevalence data, it is not likely that the general population in MENA is experiencing or will experience such a considerable HIV epidemic. Nevertheless, the risk for concentrated HIV epidemics among several high-risk core groups is high. Conclusions HSV-2 prevalence surveys provide a useful mechanism for identifying and corroborating populations at risk for HIV within MENA. HSV-2 serology offers an effective tool for probing hidden risk behaviors in a region where quality behavioral data are limited.

show abstract

High risk HPV types in southern Iranian patients with cervical cancer

Cited by 31 publications

References 24 publications

The prevalence and pattern of HPV-16 immunostaining in uterine cervical carcinomas in Ethiopian women: a pilot study

The prevalence and pattern of HPV-16 immunostaining in uterine cervical carcinomas in Ethiopian women: a pilot study

Prevalence of cervical neoplastic lesions and Human Papilloma Virus infection in Egypt: National Cervical Cancer Screening Project

HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa

Contact Info

Product

Resources

About